365 related articles for article (PubMed ID: 32068231)
1. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
4. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
5. Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors.
Xiao F; Liu D; Guo Y; Shi B; Song Z; Tian Y; Liang C
PLoS One; 2013; 8(10):e78271. PubMed ID: 24205175
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic value of machine-learning-based model for predicting the malignancy of solid nodules in multiple pulmonary nodules].
Zhang K; Wei ZH; Wang X; Chen KZ
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):573-579. PubMed ID: 35658345
[No Abstract] [Full Text] [Related]
7. Evaluating the Patient With a Pulmonary Nodule: A Review.
Mazzone PJ; Lam L
JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of multiclassification prediction models for pulmonary nodules based on machine learning.
Liu Q; Lv X; Zhou D; Yu N; Hong Y; Zeng Y
Clin Respir J; 2024 May; 18(5):e13769. PubMed ID: 38736274
[TBL] [Abstract][Full Text] [Related]
10. Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant?
Uthoff J; Koehn N; Larson J; Dilger SKN; Hammond E; Schwartz A; Mullan B; Sanchez R; Hoffman RM; Sieren JC;
Eur Radiol; 2019 Oct; 29(10):5367-5377. PubMed ID: 30937590
[TBL] [Abstract][Full Text] [Related]
11. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Machine Learning-based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts.
Chen K; Nie Y; Park S; Zhang K; Zhang Y; Liu Y; Hui B; Zhou L; Wang X; Qi Q; Li H; Kang G; Huang Y; Chen Y; Liu J; Cui J; Li M; Park IK; Kang CH; Shen H; Yang Y; Guan T; Zhang Y; Yang F; Kim YT; Wang J
Clin Cancer Res; 2021 Apr; 27(8):2255-2265. PubMed ID: 33627492
[TBL] [Abstract][Full Text] [Related]
13. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.
Tanner NT; Aggarwal J; Gould MK; Kearney P; Diette G; Vachani A; Fang KC; Silvestri GA
Chest; 2015 Dec; 148(6):1405-1414. PubMed ID: 26087071
[TBL] [Abstract][Full Text] [Related]
14. Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
Choi HK; Ghobrial M; Mazzone PJ
Ann Am Thorac Soc; 2018 Oct; 15(10):1117-1126. PubMed ID: 30272500
[TBL] [Abstract][Full Text] [Related]
15. A prediction model to evaluate the pretest risk of malignancy in solitary pulmonary nodules: evidence from a large Chinese southwestern population.
Wu Z; Huang T; Zhang S; Cheng D; Li W; Chen B
J Cancer Res Clin Oncol; 2021 Jan; 147(1):275-285. PubMed ID: 33025281
[TBL] [Abstract][Full Text] [Related]
16. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
[TBL] [Abstract][Full Text] [Related]
17. Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5-30 mm pulmonary nodules: a retrospective analysis.
Jiang Y; Deng T; Huang Y; Ren B; He L; Pang M; Jiang L
PeerJ; 2023; 11():e16539. PubMed ID: 38107565
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
Xiao F; Yu Q; Zhang Z; Liu D; Liang C
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
[TBL] [Abstract][Full Text] [Related]
19. [Multivariate Analysis of Solid Pulmonary Nodules Smaller than 1 cm in
Distinguishing Lung Cancer from Intrapulmonary Lymph Nodes].
Tang J; Liu C; Wang P; Cui Y
Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):94-98. PubMed ID: 33508896
[TBL] [Abstract][Full Text] [Related]
20. [Value of peripheral blood rare cell EGFR gene amplification detection in the evaluation of benign and malignant pulmonary nodules].
Li H; Liu XQ; Yan LJ; Liu Y; Zhang JQ; Xiao YN; Li SQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1584-1589. PubMed ID: 38742345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
